Separable multidimensional MRI signatures of cellular and structural pathology in Alzheimer's disease

Eppu Manninen1, Courtney J Comrie2, Geidy E Serrano3

  • 1Multiscale Imaging and Integrative Biophysics Unit, Laboratory of Behavioral Neuroscience, National Institute on Aging, NIH, Baltimore, MD, 21224, USA.

Insights

Multidimensional MRI (MD-MRI) reveals distinct microstructural signatures of Alzheimer's disease (AD) pathologies like tau and myelin. These signatures correlate with cognitive decline, offering new ways to assess AD progression.

Area of Science:

  • Neuroimaging
  • Neuropathology
  • Biomedical Engineering

Background:

  • Alzheimer's disease (AD) cognitive decline involves microstructural changes, but MRI signal origins are unclear.
  • Multidimensional diffusion-relaxation MRI (MD-MRI) can resolve tissue heterogeneity, potentially linking MRI signals to pathology.

Purpose of the Study:

  • To test if neuronal, glial, and white matter pathologies in AD occupy distinct diffusion-relaxation spaces.
  • To determine if these pathologies generate spatially organized imaging signatures linked to cognitive impairment.

Main Methods:

  • Integrated ex vivo MD-MRI with histology from 12 human donors across Braak stages.
  • Used nested cross-validated elastic net modeling to predict Aβ, pTau, microglia, and myelin burden from MD-MRI data.
  • Assessed regional associations in the hippocampus and white matter, correlating predictions with Mini-Mental State Examination (MMSE) scores.

Main Results:

  • Distinct diffusion-relaxation components were associated with specific pathological markers (myelin, pTau, microglia, Aβ).
  • Predicted pathology patterns matched known AD vulnerabilities in hippocampal subfields and white matter.
  • Higher predicted pTau in the hippocampus strongly correlated with worse cognitive performance (ρ = -0.88).

Conclusions:

  • MD-MRI signatures are directly linked to histologically verified cellular pathology in AD.
  • AD processes manifest as distinct, spatially organized diffusion-relaxation signatures.
  • MD-MRI has potential for mapping regionally specific neuropathology and assessing cognitive impairment in vivo.